Abstract:BACKGROUND/AIMS: Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that binds to the antioxidant response element(s) (ARE) in target gene promoters, enabling oxidatively stressed cells to respond in order to restore redox homeostasis. Post-translational modifications (PTMs) that mediate activation of Nrf2, in the cytosol and its release from Keap1, have been extensively studied but PTMs that impact its biology after activation are beginning to emerge. In this regard, PTMs like acetylation, phosphorylation, ubiquitination and sumoylation contribute towards the Nrf2 subcellular localization, and its transactivation function. We previously demonstrated that Nrf2 traffics to the promyelocytic leukemia-nuclear bodies (PML-NB), where it is a target for modification by small ubiquitin-like modifier (SUMO) proteins (sumoylation), but the site(s) for SUMO conjugation have not been determined. In this study, we aim to identify SUMO-2 conjugation site(s) and explore the impact, sumoylation of the site(s) have on Nrf2 stability, nuclear localization and transcriptional activation of its target gene expression upon oxidative stress. METHODS: The putative SUMO-binding sites in Nrf2 for human isoform1 (NP_006155.2) and mouse homolog (NP_035032.1) were identified using a computer-based SUMO-predictive software (SUMOplotTM). Site-directed mutagenesis, immunoblot analysis, and ARE-mediated reporter gene assays were used to assess the impact of sumoylation on these site(s) in vitro. Effect of mutation of these sumoylation sites of Nrf2 on expression of Heme Oxygenase1 (HO-1) was determined in HEK293T cell. RESULTS: Eight putative sumoylation sites were identified by SUMOplotTM analysis. Out of the eight predicted sites only one 532LKDE535 of human (h) and its homologous 524LKDE527 of mouse (m) Nrf2, exactly matches the SUMO-binding consensus motif. The other high probability SUMO-acceptor site identified was residue K110, in the motifs 109PKSD112 and 109PKQD112 of human and mouse Nrf2, respectively. Mutational analysis of putative sumoylation sites (human (h)/mouse (m) K110, hK533 andmK525)showed that these residues are needed for SUMO-2 conjugation, nuclear localization and ARE driven transcription of reporter genes and the endogenous HO-1 expression by Nrf2. These residues also stabilized Nrf2, as evident from shorter half-lives of the mutant protein compared to wild-type Nrf2. CONCLUSION: Our findings indicate that SUMO-2 mediated sumoylation of K110 and K533 in human Nrf2 regulates in part its transcriptional activity by enhancing its stabilization and nuclear localization.

Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1)

Sumoylation of TCF21 downregulates the transcriptional activity of estrogen receptor-alpha.

Regulation of transcription factors by sumoylation

SUMO functions in constitutive transcription and during activation of inducible genes in yeast

SUMO modification regulates the transcriptional activity of XBP1.

SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution

SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells

SUMOylation of the M6a-Rna Methyltransferase METTL3 Modulates Its Function.

Differential Regulation of C-Jun-dependent Transcription by SUMO-specific Proteases.

SUMOylation Represses the Transcriptional Activity of the Unfolded Protein Response Transducer ATF6.

Role of SUMO in Gene Transcriptional Repression

Regulation of Epithelial–Mesenchymal Transition through SUMOylation of Transcription Factors

SUMO-2 Promotes Mrna Translation by Enhancing Interaction Between Eif4e and Eif4g.

Protein modification by SUMO.

SUMO-Modification of Human Nrf2 at K110 and K533 Regulates Its Nucleocytoplasmic Localization, Stability and Transcriptional Activity

Regulation of SUMOylation on RNA Metabolism in Cancers

SUMO suppresses and MYC amplifies transcription globally by regulating CDK9 sumoylation

SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic Studies

SUMO1 Enhances 17-Beta Estradiol's Effect on CRH Promoter Activation Through Estrogen Receptors.

RSRC1 SUMOylation Enhances SUMOylation and Inhibits Transcriptional Activity of Estrogen Receptor Β.

SUMOylation down-regulates rDNA transcription by repressing expression of upstream-binding factor and proto-oncogene c-Myc